India's Capex Comeback: Explore Small Cap Stock Opportunities
Here is the latest financial fact sheet of ARTEMIS GLOBAL LIFE SCIENCE. For more details, see the ARTEMIS GLOBAL LIFE SCIENCE quarterly results and ARTEMIS GLOBAL LIFE SCIENCE share price. For a sector overview, read our pharmaceuticals sector report.
1 Day | % | 0.0 |
No. of shares | m | 66.19 |
1 Week | % | 2.1 |
1 Month | % | -0.7 |
1 Year | % | -29.7 |
52 week H/L | Rs | 88.9/42.1 |
No. of Mths Year Ending |
12 Mar-15* |
12 Mar-16* |
12 Mar-17* |
12 Mar-18* |
12 Mar-19* |
5-Yr Chart Click to enlarge
|
---|
ARTEMIS GLOBAL LIFE SCIENCE EQUITY SHARE DATA | |||||||
---|---|---|---|---|---|---|---|
High | Rs | NA | NA | NA | 159 | 114 | |
Low | Rs | NA | NA | NA | 93 | 53 | |
Sales per share (Unadj.) | Rs | 0 | 0 | 70.0 | 76.0 | 82.6 | |
Earnings per share (Unadj.) | Rs | -0.6 | 1.5 | 4.1 | 4.0 | 3.1 | |
Diluted earnings per share | Rs | -0.0 | 0.0 | 4.1 | 4.0 | 3.1 | |
Cash flow per share (Unadj.) | Rs | -0.6 | 1.5 | 6.4 | 6.8 | 6.1 | |
Dividends per share (Unadj.) | Rs | 0 | 0 | 0 | 0 | 0 | |
Adj. dividends per share | Rs | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Avg Dividend yield | % | 0 | 0 | 0 | 0 | 0 | |
Book value per share (Unadj.) | Rs | 5.0 | 2.5 | 37.3 | 41.3 | 44.3 | |
Adj. book value per share | Rs | 0.0 | 0.0 | 37.3 | 41.3 | 44.3 | |
Shares outstanding (eoy) | m | 0.10 | 0.50 | 66.19 | 66.19 | 66.19 | |
Price / Sales ratio | x | 0 | 0 | 0 | 1.7 | 1.0 | |
Avg P/E ratio | x | 0 | 0 | 0 | 31.8 | 27.2 | |
P/CF ratio (eoy) | x | 0 | 0 | 0 | 18.5 | 13.7 | |
Price / Book Value ratio | x | 0 | 0 | 0 | 3.1 | 1.9 | |
Dividend payout | % | 0 | 0 | 0 | 0 | 0 | |
Avg Mkt Cap | Rs m | 0 | 0 | 0 | 8,351 | 5,548 | |
Total wages/salary | Rs m | 0 | 0 | 813 | 907 | 973 |
ARTEMIS GLOBAL LIFE SCIENCE INCOME DATA | |||||||
---|---|---|---|---|---|---|---|
Net Sales | Rs m | 0 | 0 | 4,633 | 5,028 | 5,465 | |
Other income | Rs m | 0 | 4 | 63 | 43 | 40 | |
Total revenues | Rs m | 0 | 4 | 4,696 | 5,071 | 5,505 | |
Gross profit | Rs m | 0 | -2 | 512 | 588 | 638 | |
Depreciation | Rs m | 0 | 0 | 155 | 188 | 201 | |
Interest | Rs m | 0 | 0 | 94 | 94 | 110 | |
Profit before tax | Rs m | 0 | 1 | 326 | 349 | 367 | |
Minority Interest | Rs m | 0 | 0 | 0 | 0 | 0 | |
Prior Period Items | Rs m | 0 | 0 | 0 | 0 | 0 | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Tax | Rs m | 0 | 1 | 54 | 86 | 164 | |
Profit after tax | Rs m | 0 | 1 | 271 | 263 | 204 | |
Gross profit margin | % | 0 | 0 | 11.0 | 11.7 | 11.7 | |
Effective tax rate | % | 0 | 49.2 | 16.7 | 24.7 | 44.5 | |
Net profit margin | % | 0 | 0 | 5.9 | 5.2 | 3.7 |
ARTEMIS GLOBAL LIFE SCIENCE BALANCE SHEET DATA | |||||||
---|---|---|---|---|---|---|---|
Current assets | Rs m | 0 | 2 | 907 | 889 | 1,125 | |
Current liabilities | Rs m | 0 | 1 | 1,374 | 1,506 | 1,767 | |
Net working cap to sales | % | 0 | 0 | -10.1 | -12.3 | -11.7 | |
Current ratio | x | 0.9 | 2.5 | 0.7 | 0.6 | 0.6 | |
Inventory Days | Days | 0 | 0 | 20 | 10 | 8 | |
Debtors Days | Days | 0 | 0 | 478 | 404 | 525 | |
Net fixed assets | Rs m | 1 | 0 | 3,784 | 4,082 | 4,418 | |
Share capital | Rs m | 1 | 1 | 132 | 132 | 132 | |
"Free" reserves | Rs m | -1 | 0 | 2,335 | 2,598 | 2,802 | |
Net worth | Rs m | 1 | 1 | 2,468 | 2,731 | 2,935 | |
Long term debt | Rs m | 0 | 0 | 657 | 522 | 535 | |
Total assets | Rs m | 1 | 2 | 4,692 | 4,971 | 5,543 | |
Interest coverage | x | 0 | 0 | 4.5 | 4.7 | 4.3 | |
Debt to equity ratio | x | 0 | 0 | 0.3 | 0.2 | 0.2 | |
Sales to assets ratio | x | 0 | 0 | 1.0 | 1.0 | 1.0 | |
Return on assets | % | -10.4 | 36.2 | 7.8 | 7.2 | 5.7 | |
Return on equity | % | -11.7 | 59.2 | 11.0 | 9.6 | 6.9 | |
Return on capital | % | -11.7 | 116.4 | 13.4 | 13.6 | 13.8 | |
Exports to sales | % | 0 | 0 | 0 | 0 | 0 | |
Imports to sales | % | 0 | 0 | 0 | 0 | 0 | |
Exports (fob) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Imports (cif) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Fx inflow | Rs m | 0 | 0 | 633 | 0 | 0 | |
Fx outflow | Rs m | 0 | 0 | 44 | 0 | 0 | |
Net fx | Rs m | 0 | 0 | 589 | 0 | 0 |
ARTEMIS GLOBAL LIFE SCIENCE CASH FLOW | |||||||
---|---|---|---|---|---|---|---|
From Operations | Rs m | -0 | 1 | 523 | 714 | 404 | |
From Investments | Rs m | 0 | 1 | -702 | -666 | -495 | |
From Financial Activity | Rs m | 0 | 0 | 217 | -97 | 144 | |
Net Cashflow | Rs m | -0 | 1 | 38 | -49 | 53 |
Share Holding
Shareholding as on Sep 2019
|
Company Information
|
CHM: Onkar S Kanwar | COMP SEC: Anuj Sood | YEAR OF INC: 2011 | BSE CODE: 540616 | FV (Rs): 2 | DIV YIELD (%): - |
More Steel/sponge Iron/pig Iron Company Fact Sheets: DIVIS LABORATORIES DR. REDDYS LAB SUN PHARMA ZYDUS LIFESCIENCES CIPLA
Compare ARTEMIS GLOBAL LIFE SCIENCE With: DIVIS LABORATORIES DR. REDDYS LAB SUN PHARMA ZYDUS LIFESCIENCES CIPLA
Indian share markets ended the mock trading session on a positive note tracking strong global peers and FII inflows.